What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to inform investors about a waiver granted by CVS to Caremark Rx, Inc. to issue a special cash dividend to Caremark shareholders, which is a condition tied to the pending merger between the two companies. It also announces the combined company's intention to conduct an accelerated share repurchase post-merger.

How will the special cash dividend affect Caremark shareholders?

Caremark shareholders are expected to receive a special cash dividend of $2.00 per share, payable at or immediately following the effective time of the merger. This dividend is dependent on the successful completion of the merger.

What is an accelerated share repurchase and why is CVS planning one?

An accelerated share repurchase (ASR) is a transaction where a company buys back a significant amount of its own stock from an investment bank. The intention is typically to reduce the number of outstanding shares, which can increase earnings per share (EPS) and return capital to shareholders. CVS plans to retire approximately 150 million shares post-merger, signaling a commitment to shareholder value enhancement.

Is the merger between CVS and Caremark guaranteed to happen?

While the filing details aspects of the merger agreement and related transactions like the dividend and ASR, the payment of the special cash dividend and the ASR are explicitly conditioned on the completion of the merger. Therefore, the merger is not guaranteed until all closing conditions are met.

CVS 8-K SEC Disclosure — Jan 18, 2007

Summary

This 8-K filing from CVS Health Corp. (CVS) on January 18, 2007, primarily details an amendment to the existing merger agreement with Caremark Rx, Inc. The key development is CVS granting Caremark a waiver to issue a special cash dividend of $2.00 per share to Caremark shareholders. This dividend is contingent upon the successful completion of the merger between CVS and Caremark. Furthermore, the filing discloses the intention of the combined entity to execute an accelerated share repurchase program following the merger. This program aims to retire approximately 150 million shares of the combined company's common stock, representing about 9.8% of the pro-forma outstanding shares. This action signals a significant move by management to enhance shareholder value through capital return and potential EPS accretion.

Key Highlights

1CVS granted Caremark Rx a waiver to effect a special cash dividend of $2.00 per share.
2The special cash dividend is conditioned on the completion of the merger between CVS and Caremark.
3The merger agreement was originally dated November 1, 2006, and amended on January 16, 2006.
4The combined company plans an accelerated share repurchase transaction after the merger.
5Approximately 150 million shares of the combined company's common stock will be retired through this repurchase.
6This represents about 9.8% of the combined company's pro-forma outstanding shares.
7This filing is an amendment to the Agreement and Plan of Merger with Caremark Rx, Inc.

CVS HEALTH Corp 8-K Report, Corporate Update (Jan 18, 2007)

Summary

Key Highlights

Frequently Asked Questions